There are various forms of treatment for prostate cancer. In addition to oncologic outcomes,
physicians, and increasingly patients, are focusing on functional and adverse outcomes …

Patients who have undertaken successful prostate cancer treatment have a good prognosis,
and commonly present for further interventions to optimise quality of life if bothersome …

We compared clinical outcomes associated with seed brachytherapy (SEED-BT) alone and
SEED-BT plus external-beam radiotherapy (EBRT) for intermediate-risk prostate cancer …

Background We compared the oncological outcomes of patients who received seed
brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for …

Background An association between adrenergic alpha-1 receptor antagonists and delirium
has been suggested, but the details are unclear. Aim This study investigated the association …

Introduction Silodosin determines smooth muscle relaxation in bladder and prostate tissues,
increases bladder blood flow in conditions of chronic bladder ischemia and regulates the …

Use of α-androgenic receptor blockers remains a mainstay therapeutic approach for the
treatment of urological diseases. Silodosin is recommended over other α-blockers for the …

Background Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to
the prostate while minimizing radiation to the adjacent critical organs. Large fraction sizes …

Background As the clinical effects of the available α1‐adrenoceptors (ARs) blockers are
usually considered comparable for treatment in patients suffering from lower urinary tract …

A gas chromatography tandem mass-spectrometry method dedicated to the analysis of 50
metabolites of polycyclic aromatic hydrocarbons (OH-PAHs) was applied to urine specimens …